The announcement comes just two weeks after Merck pulled its painkiller, Vioxx, which is in the same class of drugs as Bextra, from the market because a study showed that the risk of heart attacks doubled for patients who had taken Vioxx for 18 months or longer.
Food and Drug Administration said similar prescription drugs were safe.
Last week, Gilmartin and Kim still said that none of the earlier Vioxx studies, by either the company or others, convincingly showed increased heart and stroke risk from the drug.
"In light of Merck's withdrawal of Vioxx from the market and otherrecent news
